| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2001-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87851346b29456db2fa39c8caabf7e30 |
| publicationDate |
2002-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002099001-A1 |
| titleOfInvention |
Oral delivery of chemically modified proteins |
| abstract |
Provided are compositions and methods for oral delivery of chemically modified proteins, including chemically modified G-CSF and chemically modified consensus interferon. Uptake from the intestine to the bloodstream is demonstrated for pegylated G-CSF and pegylated consensus interferon. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646438-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008260820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7834147-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007167359-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10279029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10188698-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004229799-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10751409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018085495-A3 |
| priorityDate |
1994-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |